<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04178707</url>
  </required_header>
  <id_info>
    <org_study_id>UMUmea</org_study_id>
    <nct_id>NCT04178707</nct_id>
  </id_info>
  <brief_title>Anal Fistula and Microdialysis - What is Yet to Learn?</brief_title>
  <official_title>Intervention With Microdialysis Measurements in Anal Fistula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ume책</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ume책</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anal Fistula can be a challenging condition to treat. Microdialysis has never before been
      used to examine the inner environment of anal fistula. This is now going to be performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with anal fistula can have a reduced quality of life for years do to fistula
      complications. This condition is not well researched and more knowledge is needed to provide
      better care. Microdialysis has been used to study other organs of the body such as the brain,
      liver and GI-tract. Upcoming study is going to study the inner environment of the anal
      fistula in regards to lactate, pyruvate and glucose.

      The study group is patients with anal fistula that with a need for seton treatment.
      Measurements with microdialysis will take place before operative procedure and one month
      after getting their seton inserted.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 10, 2019</start_date>
  <completion_date type="Anticipated">May 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Microdialysis is used to investigate the inner enviorment of anal fistulas. The patient will be its own control with measurements at prior to intervention and after operative procedure.</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measurements of glucose in anal fistula using microdialysis</measure>
    <time_frame>baseline measurement, 1 month follow up</time_frame>
    <description>measurements of glucose in fistula using microdialysis, change in value is being assessed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>measurement of pyruvate in anal fistula using microdialysis</measure>
    <time_frame>baseline measurement, 1 month follow up</time_frame>
    <description>measurement of pyruvate measurements in fistula using microdialysis, change in value is being assessed</description>
  </secondary_outcome>
  <other_outcome>
    <measure>measurement of lactate in anal fistula using microdialysis</measure>
    <time_frame>baseline measurement, 1 month follow up</time_frame>
    <description>measurement of lactate in fistula using microdialysis, change in value is being assessed</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Anal Fistula</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Using microdialysis the patients inner enviorment of the anal fistula will be measured - levels of lactate, glucose and pyruvate.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OnZurf Probe, Senzime AB, Uppsala, Sweden</intervention_name>
    <description>Probe is inserted into the fistula and measurements are made of the inner environment.</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  over 18 years of age

          -  to be able to understand and accept the terms of study

        Exclusion Criteria:

          -  age under 18

          -  dementia, language barrier
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ulf Gunnarsson, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital, Ume책</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karin Strigard, Associate Professor</last_name>
    <phone>+4673 382 0772</phone>
    <email>karin.strigard@umu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Karin Adamo, PhD student</last_name>
    <phone>-46703364755</phone>
    <email>karin.adamo@umu.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Umea University Hospital</name>
      <address>
        <city>Umea</city>
        <state>Vasterbotten</state>
        <zip>90381</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Stigard, Associate Professor</last_name>
      <phone>+46733820772</phone>
      <email>karin.strigard@umu.se</email>
    </contact>
    <contact_backup>
      <last_name>Karin Adamo, MD</last_name>
      <phone>+46703364755</phone>
      <email>karin.adamo@umu.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 25, 2019</study_first_submitted>
  <study_first_submitted_qc>November 24, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 26, 2019</study_first_posted>
  <last_update_submitted>December 11, 2019</last_update_submitted>
  <last_update_submitted_qc>December 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Ume책</investigator_affiliation>
    <investigator_full_name>Karin Gustafsson</investigator_full_name>
    <investigator_title>Medical Doctor, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Fistula</mesh_term>
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

